Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients

This study has been completed.
Sponsor:
Collaborator:
Azienda Ospedaliera Universitaria Policlinico
Information provided by:
Universita di Verona
ClinicalTrials.gov Identifier:
NCT01113853
First received: April 28, 2010
Last updated: April 30, 2010
Last verified: January 2007

April 28, 2010
April 30, 2010
January 2007
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01113853 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients
Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients Stopping Anti-inflammatory Treatment

Previous studies have demonstrated that exhaled nitric oxide can be useful to monitor the efficacy of anti-inflammatory treatment as well as to predict a risk of asthma relapse in asthmatic patients.

The aim of the present study is to evaluate the time course of exhaled nitric oxide in mild asthmatic patients, stopping regular treatment with inhaled corticosteroids, if it is possible, in relationship with symptoms and lung function.

All patients were evaluated with pulmonary lung function, exhaled nitric oxide and peak expiratory flow (PEF) and fill in a personal diary for the first two weeks when patients are in treatment; the same evaluation will be made for other four weeks without treatment.

Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Probability Sample

children with asthma visited in the outpatients clinic at University of Verona were invited to participate to the study

Asthma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
January 2010
Not Provided

Inclusion Criteria:

  • mild asthmatic treated with low dose inhaled steroids for whom it has to be considered stop of steroid treatment according to GINA guidelines

Exclusion Criteria:

  • age < 5 years
  • chronic respiratory diseases
Both
5 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Italy
 
NCT01113853
AOV 1360
No
attilio L Boner, Università di Verona
Universita di Verona
Azienda Ospedaliera Universitaria Policlinico
Principal Investigator: Giorgio L Piacentini, MD University of Verona
Universita di Verona
January 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP